Meta Pixel

News and Announcements

Oz Medicann Group launches new education initiative with University of New England

  • Published September 17, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Oz Medicann Group (OMG) Pty Ltd is thrilled to announce our new education initiative in conjunction with the University of New England. This program will be run mainly through Educann P/L, a subsidiary with a focus on educating patients and carers, health practitioners, cultivators and the general public. Through this program, called Nucleate, OMG will introduce university students to the medicinal cannabis industry and allow them the opportunity to work toward overcoming industry challenges.

Although the program is offered through the University of New England School of Business, it is open to students from all areas of study as a means of preparing students to assume the wide variety of roles that are vital to the success of this burgeoning industry. Over the course of this 6-week unit, students will participate four weeks of online courses and a 2-day intensive workshop in Armidale, NSW. Two experts, Alice Howard-Vyse and Tida Tippapart, will be working closely with the students on the general side of success in up-and-coming industries, while OMG will be providing specific industry information, including the challenges we currently face.

This program is yet another example of OMG’s commitment to building the new agribusiness of medicinal cannabis here in Australia. In order for this new field to thrive, there must be educated young professionals with the necessary skills and information needed to be industry leaders. By investing in the students of Australia, Oz Medicann Group is investing in the future.

The University of New England is one of the many partnerships we have established. Other partnerships and relationships include:

  • National Institute for Complementary Medicine
  • University of Western Sydney
  • University of New England

One of the main ways OMG strives to attain our goal of “Controlling the chain from seedling to consumer and from researcher to patient” is through our collaborative efforts as mentioned above. To us, collaboration is the first essential step to innovation. Our success as a patient-centric healthcare company relies upon it. For more information on the Nucleate program, visit https://www.une.edu.au/about-une/faculty-of-science-agriculture-business-and-law/unebs/une-
naturally-entrepreneurial/nucleate.

If interested in joining the Oz Medicann group as an investor, team-member, or community member register your interest now.

Register Interest

About Oz Medicann

OZ Medicann is a leading Australian Cannabis and Hemp cultivator that produces medicinal solutions, consumer products and education programs for medical practitioners.

Register Interest

Capital Insights
How Capital HQ Slashes Capital Raising Time by 80% for Founders

For startup founders, the capital raise process can feel like a relentless, time-consuming marathon, often diverting precious energy from the core business. “I remember finishing a capital raise at one stage and I remember spending about three months on it and for the money was brought in I thought that money could have been generated […]

Capital Insights
The Great Convergence: The $19 Trillion Shift Defining the Next Era of Wealth

A quiet but powerful trend is re-architecting global finance: the great convergence of traditional finance and digital assets. With Boston Consulting Group forecasting the tokenized real-world assets market to hit $16 trillion by 2030, this isn’t speculation—it’s a new institutional reality. Discover the infrastructure being built, the power of tokenization, and how mature DeFi strategies are defining the next era of wealth.

Join over 45,000+ sophisticated investors

Join Now